𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of complement activation by intravenous immunoglobulins

✍ Scribed by Ming Qi; JÜRg A. Schifferli


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
121 KB
Volume
38
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Inhibition of bFGF activity by complemen
✍ Hisako Sakiyama; Kazuhiko Kaji; Koichi Nakagawa; Ken Nagino 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

The ®rst complement component C1s formed large aggregates with bFGF when bFGF and C1s were incubated at 378C overnight. Under non-reducing conditions, a part of the aggregates did not penetrate into 5% polyacrylamide gel in the presence of SDS, and the rest penetrated into 5% gel but not into 12% ge

Acquired von willebrand disease: Correct
✍ Dr. A. Delmer; M. H. Horellou; J. M. Bréchot; J. Prudent; F. Potevin; C. Lecrubi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

High-dose intravenous immunoglobulins (ivlG) were used in a 57-year-old patient with acquired von Willebrand disease in order to correct a hemostatic defect before pneumonectomy for lung carcinoma. IvlG induced a rapid and complete correction of factor Vlll (F VIII) and von Willebrand factor (vWF) a

Inhibition of atypical PKC blocks ultrav
✍ Chuanshu Huang; Jingxia Li; Nanyue Chen; Wei-ya Ma; G. Tim Bowden; Zigang Dong 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

Since ultraviolet (UV) radiation is a major etiologic factor in the development of human skin cancers, investigating the signal transduction pathways initiated by UV radiation may help with the understanding of the molecular mechanisms of UV-induced carcinogenesis. Our previous studies demonstrated